As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Influenza Vaccine Market: By Vaccine Type: Quadrivalent, Trivalent; By Technology: Egg-based, Cell-based; By Age Group: Paediatric, Adult; By Route of Administration: Injection, Nasal spray; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Influenza Vaccine Market Outlook

The global influenza vaccine market attained a volume of about USD 5.1 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 7.34% to reach nearly USD 7.8 billion by 2026.

 

Rising Awareness Regarding the Importance of Influenza Vaccines Aiding the Market Growth

The increasing awareness regarding the benefits of influenza to prevent adverse side effects of influenza infection is augmenting the market growth. Various governments bodies such as the Food and Drug Administration (FDA) of the United States and the European Commission, among others, are increasingly authorising effective influenza vaccines. This, in turn, is preventing the spread of the disease and increasing the healthcare quality, hence driving the market growth. Furthermore, the growing demand for innovative zoonotic influenza vaccines to prevent the potential spread of influenza from animals is providing impetus to the growth of the market.

The market for influenza vaccine is being aided by the growing demand for influenza vaccines in developing countries due to the high prevalence of influenza-related deaths. Moreover, various governments are increasingly providing influenza vaccines for children to prevent the surge of complicated health issues. As the monsoon season in developing countries results in a surge in cases of influenza, routine administration of vaccines against the disease is recommended, which is significantly contributing to the growth of the market. In addition, the initiation of various research activities by governments to develop a vaccine that provides protection against various strains of the influenza virus is predicted to drive the market growth in the forecast period.

 

Influenza Vaccine: Industry Definition and Segmentation

An influenza vaccine, variously known as a flu vaccine, is a vaccine that provides protection against the various strains of influenza. As influenza is most prevalent in the monsoon season, the vaccine prevents the risk of influenza-related complications like ear infections and bacterial pneumonia. An influenza vaccine is one of the most crucial vaccinations to bolster the quality of life.

The major vaccine types of influenza vaccine are:

  • Quadrivalent
  • Trivalent

The market can be broadly categorised on the basis of its technologies into:

  • Egg-based
  • Cell-based

By age group, the market is divided into:

  • Paediatric
  • Adult

Based on route of administration, the industry is classified into:

  • Injection
  • Nasal spray

The EMR report looks into the regional markets of influenza vaccine like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Growing Demand for Innovative and Advanced Influenza Vaccines to Drive the Market Growth

The market is being aided by the growing adoption of cold-adapted influenza virus vaccines to boost the efficacy and safety of vaccination. Moreover, such vaccines do not result in any adverse side effects, due to which they are increasingly preferred for children. As cold-adapted vaccines can be administered through a nasal spray, they are ideal for the trypanophobic population, which is bolstering the growth of the market. Moreover, the increasing approvals of cold-adapted influenza vaccines by healthcare bodies are driving the growth of the influenza vaccine industry.

Advancements in vaccination technology are leading to the development of influenza vaccines from negative-strand RNA virus, which is predicted to propel the growth of the market. Moreover, the development of effective mRNA vaccines against SARS-CoV-2 during the COVID-19 crisis is leading to a surge in research activities to develop efficient mRNA influenza vaccines, which is expected to significantly contribute to the market growth. In addition, various studies and clinical trials are initiated by leading companies to determine the benefits, immunogenicity, and safety of the mRNA influenza vaccine. For instance, in July 2021, Moderna dosed the first subjects of the Phase I/II clinical trials of quadrivalent seasonal influenza mRNA vaccine candidate, mRNA-1010, in the United States.

 

Key Industry Players in the Global Influenza Vaccine Market

The report presents a detailed analysis of the following key players in the global influenza vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AstraZeneca plc
  • Biodiem Limited
  • CSL Limited
  • Emergent BioSolutions Inc.
  • F. Hoffmann-La Roche AG
  • Gamma Vaccines Pty Ltd
  • GlaxoSmithKline Plc.
  • Merck and Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Vaccine Type, Technology, Age Group, Route of Administration, Region
Breakup by Vaccine Type Quadrivalent, Trivalent
Breakup by Technology Egg-based, Cell-based
Breakup by Age Group Paediatric, Adult
Breakup by Route of Administration Injection, Nasal spray
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered AstraZeneca plc, Biodiem Limited, CSL Limited, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gamma Vaccines Pty Ltd, GlaxoSmithKline Plc., Merck and Co., Inc., Pfizer Inc., Sanofi S.A., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Influenza Vaccine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Influenza Vaccine Historical Market (2017-2021) 
    8.3    Global Influenza Vaccine Market Forecast (2022-2027)
    8.4    Global Influenza Vaccine Market by Vaccine Type
        8.4.1    Quadrivalent
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Trivalent
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
    8.5    Global Influenza Vaccine Market by Technology
        8.5.1    Egg-based
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Cell-based
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Influenza Vaccine Market by Age Group
        8.6.1    Paediatric
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Adult
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
    8.7    Global Influenza Vaccine Market by Route of Administration
        8.7.1    Injection
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Nasal spray
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
    8.8    Global Influenza Vaccine Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    AstraZeneca plc
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Biodiem Limited
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    CSL Limited
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Emergent BioSolutions Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    F. Hoffmann-La Roche AG
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Gamma Vaccines Pty Ltd
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    GlaxoSmithKline Plc.
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    Merck and Co., Inc.
            12.2.8.1    Company Overview
            12.2.8.2    Product Portfolio
            12.2.8.3    Demographic Reach and Achievements
            12.2.8.4    Certifications
        12.2.9    Pfizer Inc.
            12.2.9.1    Company Overview
            12.2.9.2    Product Portfolio
            12.2.9.3    Demographic Reach and Achievements
            12.2.9.4    Certifications
        12.2.10    Sanofi S.A.
            12.2.10.1    Company Overview
            12.2.10.2    Product Portfolio
            12.2.10.3    Demographic Reach and Achievements
            12.2.10.4    Certifications
        12.2.11    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Influenza Vaccine Market: Key Industry Highlights, 2016 and 2026
2.    Global Influenza Vaccine Historical Market: Breakup by Vaccine Type (USD Billion), 2017-2021
3.    Global Influenza Vaccine Market Forecast: Breakup by Vaccine Type (USD Billion), 2022-2027
4.    Global Influenza Vaccine Historical Market: Breakup by Technology (USD Billion), 2017-2021
5.    Global Influenza Vaccine Market Forecast: Breakup by Technology (USD Billion), 2022-2027
6.    Global Influenza Vaccine Historical Market: Breakup by Age Group (USD Billion), 2017-2021
7.    Global Influenza Vaccine Market Forecast: Breakup by Age Group (USD Billion), 2022-2027
8.    Global Influenza Vaccine Historical Market: Breakup by Route of Administration (USD Billion), 2017-2021
9.    Global Influenza Vaccine Market Forecast: Breakup by Route of Administration (USD Billion), 2022-2027
10.    Global Influenza Vaccine Historical Market: Breakup by Region (USD Billion), 2017-2021
11.    Global Influenza Vaccine Market Forecast: Breakup by Region (USD Billion), 2022-2027
12.    North America Influenza Vaccine Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    North America Influenza Vaccine Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Europe Influenza Vaccine Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Europe Influenza Vaccine Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Asia Pacific Influenza Vaccine Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Asia Pacific Influenza Vaccine Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Latin America Influenza Vaccine Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Latin America Influenza Vaccine Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Middle East and Africa Influenza Vaccine Historical Market: Breakup by Country (USD Billion), 2017-2021
21.    Middle East and Africa Influenza Vaccine Market Forecast: Breakup by Country (USD Billion), 2022-2027
22.    Global Influenza Vaccine Market Structure

Key Questions Answered in the Report

In 2020, the global influenza vaccine market attained a value of nearly USD 5.1 billion.

The market is projected to grow at a CAGR of 7.34% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 7.8 billion by 2026.

The industry is being aided by the rising awareness regarding the importance of influenza vaccines, the growing authorisation of vaccines, and the high prevalence of influenza-related issues in developing countries.

The market is expected to be propelled by the growing adoption of cold-adapted influenza vaccines, advancements in vaccines technology, and the initiation of clinical trials for the development of new and innovative influenza vaccines.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major vaccine types of influenza vaccine in the industry are quadrivalent and trivalent.

The significant technologies in the market are egg-based and cell-based.

The various age groups of influenza vaccine are paediatric and adult.

The major routes of administration are injection and nasal spray.

The major players in the industry are AstraZeneca plc, Biodiem Limited, CSL Limited, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gamma Vaccines Pty Ltd, GlaxoSmithKline Plc., Merck and Co., Inc., Pfizer Inc., and Sanofi S.A., among others.

Analyst Review

The global influenza vaccine market attained a value of nearly USD 5.1 billion in 2020, driven by the rising awareness regarding the importance of influenza vaccines. Aided by advancements in vaccines technology, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 7.34%. The market is projected to reach about USD 7.8 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its vaccine types, the influenza vaccine industry can be segmented into quadrivalent and trivalent. On the basis of technologies, the industry is divided into egg-based and cell-based. By age group, the market is bifurcated into paediatric and adult. Based on route of administration, the market is segmented into injection and nasal spray. The major regional markets for influenza vaccine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AstraZeneca plc, Biodiem Limited, CSL Limited, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gamma Vaccines Pty Ltd, GlaxoSmithKline Plc., Merck and Co., Inc., Pfizer Inc., and Sanofi S.A., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER